0001178913-20-001605.txt : 20200526
0001178913-20-001605.hdr.sgml : 20200526
20200526114012
ACCESSION NUMBER: 0001178913-20-001605
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200331
FILED AS OF DATE: 20200526
DATE AS OF CHANGE: 20200526
EFFECTIVENESS DATE: 20200526
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Noked Israel Ltd
CENTRAL INDEX KEY: 0001767750
IRS NUMBER: 514562511
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-19157
FILM NUMBER: 20908753
BUSINESS ADDRESS:
STREET 1: 22 HAGEFEN ST
CITY: RAMAT HASHARON
STATE: L3
ZIP: 4725422
BUSINESS PHONE: 972-73-780-3400
MAIL ADDRESS:
STREET 1: 22 HAGEFEN ST
CITY: RAMAT HASHARON
STATE: L3
ZIP: 4725422
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001767750
XXXXXXXX
03-31-2020
03-31-2020
false
Noked Israel Ltd
22 Hagefen St
Ramat Hasharon
L3
4725422
13F HOLDINGS REPORT
028-19157
Y
Investment discretion with regard to the securities reported herein is exercised by Noked Equity L.P ("Noked Equity"), Noked Long L.P ("Noked Long"), Noked Opportunity L.P ("Noked Opportunity"), and Noked Bonds L.P ("Noked Bonds") (jointly, the "Partnerships"). The Partnerships are managed, controlled, and operated by their general partners, as follows: Noked Capital Ltd. ("Noked Capital") is the general partner of Noked Opportunity. Noked Bonds Investments Ltd. is the general partner of Noked Bonds, and 70% of its shares are held by Noked Capital. Noked Equity Investments Ltd. is the general partner of both Noked Equity and Noked Long, and 100% of its shares are held by Noked Capital. Noked Capital is held as follows (each, a "Noked Capital Shareholder"): 11.3% of its shares are held by Taga S.P. (a company fully-owned by Ariel Hilkiyahu), 41.2% of its shares are held by Noked Israel (2011) Ltd. (a company fully-owned by Roy and Michal Vermous), 18% of its shares are held by AYT (a company fully-owned by Shay Itzhaki) and 29.5% of its shares are held by G.I.O. (a company fully-owned by Shlomi Bracha). This Form 13F shall not be construed as an admission by Noked Capital, the general partners, any of Noked Capital Shareholders (including their ultimate shareholders) or any of the Partnerships that it is the beneficial owner of any of the securities covered by this Form 13F, and each of Noked Capital, the general partners, the Noked Capital Shareholders and the Partnerships disclaim beneficial ownership of any such securities. Per informal guidance received from the Division of Investment Management, section 13(f) securities that are dual listed on a U.S. stock exchange and the Tel Aviv Stock Exchange were included in this Form 13F only if they were purchased in the U.S.
Roy Vermus
Director
972-50-2002002
/s/ Roy Vermus
Tel Aviv
L3
05-26-2020
0
19
55987
INFORMATION TABLE
2
infotable.xml
ALIBABA GROUP HLDG LTD
SPONSORED ADS
01609W102
1345
6915
SH
DFND
6915
0
0
AMAZON COM INC
COM
023135106
1306
670
SH
DFND
670
0
0
ELLOMAY CAPITAL LTD
SHS
M39927120
284
20000
SH
DFND
20000
0
0
G WILLI FOOD INTL LTD
ORD
M52523103
1313
117257
SH
DFND
117257
0
0
ITAMAR MED LTD
SPONSORED ADS
465437101
174
14752
SH
DFND
14752
0
0
MICROSOFT CORP
COM
594918104
6096
38655
SH
DFND
38655
0
0
NUTRIEN LTD
COM
67077M108
3055
90000
SH
DFND
90000
0
0
ORMAT TECHNOLOGIES INC
COM
686688102
2030
30000
SH
DFND
30000
0
0
CIM COML TR CORP
COM NEW
125525584
1346
121407
SH
DFND
121407
0
0
RADA ELECTR INDS LTD
COM PAR NEW
M81863124
5085
1452723
SH
DFND
1452723
0
0
SAPIENS INTL CORP N V
SHS
G7T16G103
469
24640
SH
DFND
24640
0
0
SOLAREDGE TECHNOLOGIES INC
COM
83417M104
9948
121498
SH
DFND
121498
0
0
TEVA PHARMACEUTICAL INDS LTD
SPONSORED ADS
881624209
23303
2595000
SH
DFND
2595000
0
0
XTL BIOPHARMACEUTICALS LTD
SPONSORED ADR NE
98386D307
234
198888
SH
DFND
198888
0
0